no data ≤ 7.5 7.5–15 15–22.5 22.5–30 30–37.5 37.5–45 | 45–52.5 52.5–60 60–67.5 67.5–75 75–82.5 ≥ 82.5 |
No data <100 100–200 200–300 300–400 400–500 500–600 | 600–700 700–800 800–900 900–1,000 1,000–1,500 >1,500 |
Globally, an estimated 537 million adults are living with diabetes, according to 2019 data from the International Diabetes Federation. [1] Diabetes was the 9th-leading cause of mortality globally in 2020, attributing to over 2 million deaths annually due to diabetes directly, and to kidney disease due to diabetes. [2] The primary causes of type 2 diabetes is diet and physical activity, which can contribute to increased BMI, poor nutrition, hypertension, alcohol use and smoking, while genetics is also a factor. [3] Diabetes prevalence is increasing rapidly; previous 2019 estimates put the number at 463 million people living with diabetes, [4] with the distributions being equal between both sexes incidence peaking around age 55 years old. [5] The number is projected to 643 million by 2030, [1] or 7079 individuals per 100,000, with all regions around the world continue to rise. [5] Type 2 diabetes makes up about 85-90% of all cases. [6] [7] Increases in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. [8] The prevalence of African Americans with diabetes is estimated to triple by 2050, while the prevalence of white Americans is estimated to double. [3] The overall prevalence increases with age, with the largest increase in people over 65 years of age. [3] The prevalence of diabetes in America is estimated to increase to 48.3 million by 2050. [3]
Diabetes mellitus occurs throughout the world, but is more common (especially type 2) in the more developed countries. The greatest increase in prevalence is, however, occurring in low- and middle-income countries [8] including in Asia and Africa, where most patients will probably be found by 2030. [9] The increase in incidence in developing countries follows the trend of urbanization and lifestyle changes, including increasingly sedentary lifestyles, less physically demanding work and the global nutrition transition, marked by increased intake of foods that are high energy-dense but nutrient-poor (often high in sugar and saturated fats, sometimes referred to as the Western pattern diet). [8] [9] The risk of getting type 2 diabetes has been widely found to be associated with lower socio-economic position across countries. [10]
The WHO estimates that diabetes resulted in 1.5 million deaths in 2012, making it the 8th leading cause of death. [8] However another 2.2 million deaths worldwide were attributable to high blood glucose and the increased risks of associated complications (e.g. heart disease, stroke, kidney failure), which often result in premature death and are often listed as the underlying cause on death certificates rather than diabetes. [8] [11] The burden of diabetes (both type 1 and 2) has a possibility to lead to complications of multiple body systems including nephropathy, neuropathy and retinopathy. [12] About half of patients with type 2 diabetes die due to cardiovascular disease and 10% from kidney failure. [13] A study done on Gomel city population with radiation exposure after the Chernobyl incident demonstrated increased incidence of type 1 diabetes mellitus. [14] [15] Women who had gestational diabetes during pregnancy have a 20-50% increased risk of developing type 2 diabetes later in life. [3]
Almost one Chinese adult in four has diabetes. [1] The International Diabetes Federation estimated in 2021 more than 140 million Chinese adults with diabetes. [1] The incidence of the disease is increasing rapidly: a reported 30% increase in 7 years. [16] Indigenous nomadic peoples like Tibetans and Mongols are at much higher susceptibility than Han Chinese.
India has the second highest number of people with diabetes. [1] Diabetes currently affects more than 74 million Indians, which is more than 8.3% of the adult population. [1] It is estimated to be around 57% of the current cases of diabetes to be undiagnosed.
[17] Among young and middle aged adults the prevalence of diabetes is 6.7% and prediabetes is 5.6% according to the National Family Health Survey-4. [18] The average age on onset is 42.5 years. [19] Nearly 1 million Indians die due to diabetes every year. [19]
According to the Indian Heart Association, India is projected to be home to 109 million individuals with diabetes by 2035. [20] A study by the American Diabetes Association reports that India will see the greatest increase in people diagnosed with diabetes by 2030. [21] The high incidence is attributed to a combination of genetic susceptibility plus adoption of a high-calorie, low-activity lifestyle by India's growing middle class. [22]
In 2021, Japan had an estimated 11 million people with diabetes, an increase from 7.1 million in 2000. [23] This is around 1 in 10 adults.
In 2021 there were 4.1 million people in the UK diagnosed with diabetes, 90% of them having type 2. There were a further 1 million people with undiagnosed type 2 diabetes and 13.6 million people were at risk of developing type 2 diabetes, half of which could be prevented. [24] The charity Diabetes UK have made predictions that could become high as 6.2 million by 2035–2036. The National Health Service (NHS) spent a daily average of £2.2m (€2.6m; $3.7m) in 2013 on prescriptions for managing diabetes in primary care, and about 10% of the primary care prescribing budget is spent on treating diabetes. [25] Diabetes UK have also predicted that the NHS could be spending as much as 16.9 billion pounds on diabetes mellitus by 2035, a figure that means the NHS could be spending as much as 17% of its budget on diabetes treatment by 2035. [26] [27] However, since the United Kingdom practices a national health care system with universal access, there are far fewer cases of diagnosed diabetes compared to the United States. [28]
Almost 2.4 million Canadians (6.8%) have been diagnosed with type 1 or type 2 diabetes, based on 2009 chronic disease surveillance data. Prevalence is higher among males (7.2%) than females (6.4%). [11] However these numbers are likely an underestimate, as data obtained from blood samples indicate about 20% of diabetes cases remain undiagnosed. [29]
The prevalence of diagnosed diabetes among Canadians increased by 70% over the decade from 1999 to 2009. [11] The greatest relative increase in prevalence was seen younger adults (35 to 44 years), attributable in part to increasing rates of overweight and obesity. The Public Health Agency of Canada estimates that if current trends in diabetes continue, the number of Canadians living with diabetes will reach 3.7 million by 2019. [11]
Diabetes rates in the United States, like across North America and around the world, have been increasing substantially.The diagnosis of diabetes has quadrupled in the last 30 years in America, increasing from 5.5 million in 1980 to 21.1 million in 2010. [30] From 1988-1994, about 25% of American adults, aged 40–74 years old, were classified as having prediabetes. [3] According to the 2014 Statistics Report done by the CDC it was found that, "Diabetes Mellitus affects an estimated 29.1 million people in the United States and is the 7th leading cause of death. It also increases the chances of mortality, as well as the risk for heart attack, kidney failure, and blindness" [31] While the number of people with diabetes in the US continues to grow, the number of new cases has been declining since 2009, after decades of increases in new cases. [32] In 2014, more than 29 million people had diabetes in the United States, of whom 7 million people remain undiagnosed. [33] As of 2012 another 57 million people were estimated to have prediabetes. [34] [35] There were approximately 12.1 million diabetes-related emergency department (ED) visits in 2010 for adults aged 18 years or older (515 per 10,000 U.S. population), accounting for 9.4 percent of all ED visits. [36]
The Centers for Disease Control and Prevention (CDC) has called the change an epidemic. [37] Geographically, there is a U.S. diabetes belt with high diabetes prevalence estimates, which includes Mississippi and parts of Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and West Virginia. [38] The National Diabetes Information Clearinghouse estimates diabetes costs $132 billion in the United States alone every year. About 5%–10% of diabetes cases in North America are type 1, with the rest being type 2. The fraction of type 1 in other parts of the world differs. Most of this difference is not currently understood. The American Diabetes Association (ADA) cites the 2003 assessment of the National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention) that one in three Americans born after 2000 will develop diabetes in their lifetimes. [39] [40]
Diabetes is also more prominent in minority groups. For example, according to the American Diabetes Association the rates of diagnosed diabetes are 12.8% of Hispanics, 13.2% of Non-Hispanic blacks, 15.9% of American Indians/Alaskan Natives. While Non-Hispanic whites are 7.6% and only 9% of Asian Americans have diagnosed diabetes. [41] 4.9% of American adults had diabetes in 1990. By 1998, that number rose by a third to 6.5%. The prevalence of diabetes increased for both sexes and every racial group. American women have suffered from diabetes at a higher rate than men, with 7.4% of women being diabetic in 1998, as opposed to only 5.5% of men. The increase in diabetes coincides with an increase in average weight across both genders. In the same time frame, average weight in both men and women increased by nearly 4 kilograms. This relates to the fact that the most common form of diabetes, type 2, is strongly associated with unhealthy weight. Older Americans have suffered from diabetes at a much higher rate than younger people, with over 12% of those in their 60s and 70s being diabetic in 1998. In the same year, less than 2% of those under 30 suffered from diabetes. Weight is also a strong factor in one's likelihood of becoming diabetic, with 13.5% of obese Americans in 1998 being diabetic. In the same year, only 3.5% of people at a healthy weight had the disease. [42]
As of 2006, about 18.3% (8.6 million) of Americans age 60 and older had diabetes, according to the ADA. [43] Diabetes mellitus prevalence increases with age, and the numbers of older persons with diabetes are expected to grow as the elderly population increases in number. The National Health and Nutrition Examination Survey (NHANES III) from 1988 to 1994 demonstrated, in the population over 65 years old, 18% to 20% had diabetes, with 40% having either diabetes or its precursor form of impaired glucose tolerance. [44] Older individuals are also more likely to be seen in the emergency department (ED) for diabetes. A study by the Agency for Healthcare Research and Quality (AHRQ) found that in 2010, diabetes-related ED visit rates were highest for patients aged 65 and older (1,307 per 10,000 population), compared with 45- to 64-year-olds (584 per 10,000 population) and 18- to 44-year-olds (183 per 10,000 population). [36]
A second study by AHRQ found that diabetes with complications was one of the twenty most expensive conditions seen in U.S. inpatient hospitalizations in 2011, with an aggregate cost of nearly $5.4 billion for 561,000 stays. It was among the top five most expensive conditions for uninsured patients, at an aggregate cost of $440 million for 62,000 hospitalizations. [45]
An estimated 1.5 million Australians have diabetes. [1] Indigenous populations in developed countries generally have higher prevalence and incidence of diabetes than their corresponding nonindigenous populations. In Australia, the age-standardised prevalence of self-reported diabetes in indigenous Australians is almost four times that of nonindigenous Australians. [46] Reasons include higher rates of obesity, physical inactivity, and living in poor housing and environments among Indigenous peoples. [7] Preventative community health programs are showing some success in tackling this problem.[ citation needed ]
The International Diabetes Federation (IDF) estimates that 23.6 million are living with diabetes in Africa. [1] The region of Africa has the highest percentage of undiagnosed diabetes cases reaching 53.6%s. [1]
Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL).
In epidemiology, prevalence is the proportion of a particular population found to be affected by a medical condition at a specific time. It is derived by comparing the number of people found to have the condition with the total number of people studied and is usually expressed as a fraction, a percentage, or the number of cases per 10,000 or 100,000 people. Prevalence is most often used in questionnaire studies.
Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Other symptoms include increased hunger, having a sensation of pins and needles, and sores (wounds) that heal slowly. Symptoms often develop slowly. Long-term complications from high blood sugar include heart disease, stroke, diabetic retinopathy, which can result in blindness, kidney failure, and poor blood flow in the lower-limbs, which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.
Diseases of affluence, previously called diseases of rich people, is a term sometimes given to selected diseases and other health conditions which are commonly thought to be a result of increasing wealth in a society. Also referred to as the "Western disease" paradigm, these diseases are in contrast to "diseases of poverty", which largely result from and contribute to human impoverishment. These diseases of affluence have vastly increased in prevalence since the end of World War II.
The global pandemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), by 2023, HIV/AIDS had killed approximately 40.4 million people, and approximately 39 million people were infected with HIV globally. Of these, 29.8 million people (75%) are receiving antiretroviral treatment. There were about 630,000 deaths from HIV/AIDS in 2022. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2023, there are about 1.3 million new infections of HIV per year globally.
Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that occurs when pancreatic are destroyed by the body's immune system. In healthy persons, beta cells produce insulin. Insulin is a hormone required by the body to store and convert blood sugar into energy. T1D results in high blood sugar levels in the body prior to treatment. Common symptoms include frequent urination, increased thirst, increased hunger, weight loss, and other complications. Additional symptoms may include blurry vision, tiredness, and slow wound healing. While some cases take longer, symptoms usually appear within weeks or a few months.
Slowly evolving immune-mediated diabetes, or latent autoimmune diabetes in adults (LADA), is a form of diabetes that exhibits clinical features similar to both type 1 diabetes (T1D) and type 2 diabetes (T2D), and is sometimes referred to as type 1.5 diabetes. It is an autoimmune form of diabetes, similar to T1D, but patients with LADA often show insulin resistance, similar to T2D, and share some risk factors for the disease with T2D. Studies have shown that LADA patients have certain types of antibodies against the insulin-producing cells, and that these cells stop producing insulin more slowly than in T1D patients. Since many people develop the disease later in life, it is often misdiagnosed as type 2 diabetes.
A chronic condition is a health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include diabetes, functional gastrointestinal disorder, eczema, arthritis, asthma, chronic obstructive pulmonary disease, autoimmune diseases, genetic disorders and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin for diabetics and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.
The epidemiology of autism is the study of the incidence and distribution of autism spectrum disorders (ASD). A 2022 systematic review of global prevalence of autism spectrum disorders found a median prevalence of 1% in children in studies published from 2012 to 2021, with a trend of increasing prevalence over time. However, the study's 1% figure may reflect an underestimate of prevalence in low- and middle-income countries.
Prediabetes is a component of metabolic syndrome and is characterized by elevated blood sugar levels that fall below the threshold to diagnose diabetes mellitus. It usually does not cause symptoms but people with prediabetes often have obesity, dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is also associated with increased risk for cardiovascular disease (CVD). Prediabetes is more accurately considered an early stage of diabetes as health complications associated with type 2 diabetes often occur before the diagnosis of diabetes.
Prevention of type 2 diabetes can be achieved with both lifestyle changes and use of medication. The American Diabetes Association categorizes people with prediabetes, who have glycemic levels higher than normal but do not meet criteria for diabetes, as a high-risk group. Without intervention, people with prediabetes progress to type 2 diabetes with a 5% to 10% rate. Diabetes prevention is achieved through weight loss and increased physical activity, which can reduce the risk of diabetes by 50% to 60%.
Researcher - Dr. Dinesh Kacha Research Article - Diabetes Reversal Through Ayurvedic Lifestyle
There are a number risk factors for tuberculosis infection; worldwide the most important of these is HIV. Co-infection with HIV is a particular problem in Sub-Saharan Africa, due to the high incidence of HIV in these countries. Smoking more than 20 cigarettes a day increases the risk of TB by two to four times while silicosis increases the risk about 30 fold. Diabetes mellitus is also an important risk factor that is growing in importance in developing countries. Other disease states that increase the risk of developing tuberculosis are Hodgkin lymphoma, end-stage renal disease, chronic lung disease, malnutrition, and alcoholism. A person's genetics also play a role.
This article provides a global overview of the current trends and distribution of metabolic syndrome. Metabolic syndrome refers to a cluster of related risk factors for cardiovascular disease that includes abdominal obesity, diabetes, hypertension, and elevated cholesterol.
There are high rates of diabetes in First Nation people compared to the general Canadian population. Statistics from 2011 showed that 17.2% of First Nations people living on reserves had type 2 diabetes.
Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Diabetes accounts for approximately 4.2 million deaths every year, with an estimated 1.5 million caused by either untreated or poorly treated diabetes.
India has an estimated 212 million people with diabetes out of 828 million globally. One in four people (26%) in the world with diabetes is from India, making it the most affected country in the world.
Native Americans are affected by noncommunicable illnesses related to social changes and contemporary eating habits. Increasing rates of obesity, poor nutrition, sedentary lifestyle, and social isolation affect many Americans. While subject to the same illnesses, Native Americans have higher morbidity and mortality to diabetes and cardiovascular disease as well as certain forms of cancer. Social and historical factors tend to promote unhealthy behaviors including suicide and alcohol dependence. Reduced access to health care in Native American communities means that these diseases as well as infections affect more people for longer periods of time.
Diabetes was the eighth leading cause of death in the United States in 2020. People with diabetes are twice as likely to develop heart disease or stroke as people without diabetes. There are three types of diabetes: Type 1, Type 2, and gestational. Type 2 diabetes accounts for 90%-95% of all cases. In 2017, approximately 24.7 million people were diagnosed with diabetes in the United States, approximately 7.6% of the total population.
Hearing loss in diabetes is a form of hearing impairment resulting from type 2 diabetes mellitus. Type 2 diabetes mellitus (T2DM) is associated with various microvascular and macrovascular complications. Microvascular complications include diabetic retinopathy, neuropathy, and nephropathy, while macrovascular complications involve cerebrovascular disease, peripheral vascular disease, and coronary heart disease. T2DM also affects other systems such as the hepatic and digestive systems, musculoskeletal system, and can impact mental health and cognitive functioning. These complications significantly contribute to the disease's overall burden. The rising prevalence of T2DM is expected to increase the number of individuals experiencing these complications. Additionally, similar pathophysiological mechanisms may lead to damage in the neural system or vasculature of the inner ear, resulting in hearing impairment. Numerous population-based studies have demonstrated a significant association between T2DM and hearing loss, particularly sensorineural hearing loss, which tends to worsen as T2DM progresses.